In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...
Healthcare: Alzheimer, Altems analysis 'priority to ensure homogeneous diagnoses and treatments' (2)
(Adnkronos Health) - "The position paper produced by Altems Advisory gives substance and figures to the difficulties of patients and families, who bear the burden of territorial differences in care, ...
Global AI In Pathology Market size is expected to be worth around USD 119 Billion by 2033, from USD 27.2 Billion in 2023 ...
A new open-access cross-domain review maps how the same AI algorithms recur across IoT security, network routing, computer ...
Surgeons and statisticians from Barcelona argue that neutral machine learning results in abdominal wall surgery reveal when ...
Manufacturing managers, engineers, and IT professionals interested in AI technologySummary: This article explains real-time ...
Will the "cancer vaccine" become a leading player that surpasses Keytruda?On August 19, 2026, Moderna and Merck announced that treatment combining the personalized mRNA cancer vaccine "Intismeran Auto ...
Mayo Clinic researchers have found that artificial intelligence (AI)-enabled spatial analysis can identify patterns in routine pathology slides that may help clinicians identify which patients with ...
OpenAI’s new Astra model will use a reasoning technique called “recurrent depth” that allows it to operate outside of the sequential thinking that characterizes most reasoning models, The Information ...
“Many people worry that a recurrence is entirely out of their control,” says Elisabeth Heath, MD, chair of the department of oncology at Mayo Clinic in Rochester, Minnesota. But while no lifestyle ...
A personalized vaccine developed by Moderna Inc. and Merck & Co. reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer ...
Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results